119 related articles for article (PubMed ID: 15946906)
1. GPI-specific phospholipase D (GPI-PLD) is expressed during mouse development and is localized to the extracellular matrix of the developing mouse skeleton.
Gregory P; Kraemer E; Zürcher G; Gentinetta R; Rohrbach V; Brodbeck U; Andres AC; Ziemiecki A; Bütikofer P
Bone; 2005 Aug; 37(2):139-47. PubMed ID: 15946906
[TBL] [Abstract][Full Text] [Related]
2. Anti-mouse GPI-PLD antisera highlight structural differences between murine and bovine GPI-PLDs.
Gregory P; Ziemiecki A; Zürcher G; Brodbeck U; Bütikofer P
Biol Chem; 2003 Dec; 384(12):1575-82. PubMed ID: 14719799
[TBL] [Abstract][Full Text] [Related]
3. Skeletal-specific expression of Fgd1 during bone formation and skeletal defects in faciogenital dysplasia (FGDY; Aarskog syndrome).
Gorski JL; Estrada L; Hu C; Liu Z
Dev Dyn; 2000 Aug; 218(4):573-86. PubMed ID: 10906777
[TBL] [Abstract][Full Text] [Related]
4. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
Raikwar NS; Cho WK; Bowen RF; Deeg MA
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
[TBL] [Abstract][Full Text] [Related]
5. Genetic regulation of mouse glycosylphosphatidylinositol-phospholipase D.
Flores-Borja F; Kieszkievicz J; Church V; Francis-West PH; Schofield J; Rademacher TW; Lund T
Biochimie; 2004; 86(4-5):275-82. PubMed ID: 15194230
[TBL] [Abstract][Full Text] [Related]
6. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
[TBL] [Abstract][Full Text] [Related]
7. Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation.
Gomez C; Burt-Pichat B; Mallein-Gerin F; Merle B; Delmas PD; Skerry TM; Vico L; Malaval L; Chenu C
Dev Dyn; 2005 Oct; 234(2):393-403. PubMed ID: 16145665
[TBL] [Abstract][Full Text] [Related]
8. In vitro phosphorylation of purified glycosylphosphatidylinositol-specific phospholipase D.
Civenni G; Bütikofer P; Stadelmann B; Brodbeck U
Biol Chem; 1999 May; 380(5):585-8. PubMed ID: 10384965
[TBL] [Abstract][Full Text] [Related]
9. [Effect of overexpression of glycosylphosphatidylinositol-specific phospholipase D on biological character of hepatocellular carcinoma cell line HepG2].
He WJ; Tang JH; Tan CC; Duan Q; Wang KJ; Zuo KQ; Yuan XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):103-9. PubMed ID: 18326903
[TBL] [Abstract][Full Text] [Related]
10. Glycosylphosphatidylinositol-specific phospholipase D immunoreactivity is present in islet amyloid in type 2 diabetes.
Larson DM; Kennedy MA; Bowen RF; Verchere CB; Deeg MA
J Pathol; 2004 Aug; 203(4):961-7. PubMed ID: 15259000
[TBL] [Abstract][Full Text] [Related]
11. Studies of the role of the integrin EF-hand, Ca2+-binding sites in glycosylphosphatidylinositol-specific phospholipase D: reduced expression following mutagenesis of residues predicted to bind Ca2+.
Li JY; Low MG
Arch Biochem Biophys; 1999 Jan; 361(1):142-8. PubMed ID: 9882439
[TBL] [Abstract][Full Text] [Related]
12. Midportion antibodies stimulate glycosylphosphatidylinositol-specific phospholipase D activity.
Deeg MA; Bowen RF
Arch Biochem Biophys; 1999 Oct; 370(2):278-84. PubMed ID: 10510287
[TBL] [Abstract][Full Text] [Related]
13. Important roles of glycosylphosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma.
Tang JH; He WJ; Huang H; Tan CC; Duan Q; Wang KJ; Yuan XY; Zhu XJ
Clin Biochem; 2009 Mar; 42(4-5):400-7. PubMed ID: 19135435
[TBL] [Abstract][Full Text] [Related]
14. Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification.
Kishida Y; Hirao M; Tamai N; Nampei A; Fujimoto T; Nakase T; Shimizu N; Yoshikawa H; Myoui A
Bone; 2005 Nov; 37(5):607-21. PubMed ID: 16039170
[TBL] [Abstract][Full Text] [Related]
15. [Competitive RT-PCR assay for quantification of GPI-PLD gene expression].
Zhang XJ; Lu CP; Tang JH
Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):322-6. PubMed ID: 14653107
[TBL] [Abstract][Full Text] [Related]
16. Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment.
Elortza F; Mohammed S; Bunkenborg J; Foster LJ; Nühse TS; Brodbeck U; Peck SC; Jensen ON
J Proteome Res; 2006 Apr; 5(4):935-43. PubMed ID: 16602701
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of carcinoembryonic antigen induces metastatic potential in colorectal carcinoma.
Yamamoto Y; Hirakawa E; Mori S; Hamada Y; Kawaguchi N; Matsuura N
Biochem Biophys Res Commun; 2005 Jul; 333(1):223-9. PubMed ID: 15958210
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2-associated athanogene-1 (BAG-1): a transcriptional regulator mediating chondrocyte survival and differentiation during endochondral ossification.
Tare RS; Townsend PA; Packham GK; Inglis S; Oreffo RO
Bone; 2008 Jan; 42(1):113-28. PubMed ID: 17950682
[TBL] [Abstract][Full Text] [Related]
19. Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme.
Naghibalhossaini F; Ebadi P
Cancer Lett; 2006 Mar; 234(2):158-67. PubMed ID: 15893415
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compounds.
Brunner G; Zalkow L; Burgess E; Rifkin DB; Wilson EL; Gruszecka-Kowalik E; Powis G
Anticancer Res; 1996; 16(5A):2513-6. PubMed ID: 8917344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
